Find Academic Supervisors

• Drug Delivery
• Nanomedicine
• Biopharmaceutics
• +7 more

Dr. Shyh-Dar Li is a Professor and Tong Louie Chair in Pharmaceutical Sciences at the University of British Columbia's Faculty of Pharmaceutical Sciences, where he also serves as Chair of Nanomedicine and Chemical Biology. With a BSc in pharmacy from National Taiwan University (1998) and PhD in pharmaceutical sciences from UNC Chapel Hill (2008), followed by postdoctoral training at UC San Diego's Moores Cancer Center (2009), Dr. Li has established himself as a leading researcher in advanced drug delivery systems. His research focuses on developing innovative nanomedicine platforms for targeted delivery of biological therapeutics including peptides, proteins, antibodies, and nucleic acids. Dr. Li's laboratory has pioneered several novel drug delivery approaches, particularly in lipid-based nanoparticles, phospholipid-free vesicles, and polymer systems for cancer immunotherapy, pain management, and protein delivery. His work bridges fundamental nanotechnology with translational applications for difficult-to-treat diseases. Analysis of his recent publications reveals a strong emphasis on tumor microenvironment modulation, endosomal escape mechanisms for nucleic acid delivery, and non-invasive delivery routes for protein therapeutics. His research demonstrates increasing sophistication in nanocarrier engineering, with recent work incorporating machine learning approaches to optimize nanoparticle design and expanding into immunomodulatory therapies that harness the body's immune system to fight cancer. Scientific Recognition: 2014 AFPC New Investigator Award 2013 AAPS New Investigator Award in Pharmaceutics and Pharmaceutical Technologies 2013 CIHR New Investigator Award 2013 CSPS Early Career Award 2012 Prostate Cancer Foundation Young Investigator Award Dr. Li's research program has been consistently supported by major Canadian funding agencies including CIHR, NSERC, and MITACS. He actively collaborates across disciplines and accepts graduate students into his research program, focusing on cutting-edge approaches to overcome biological barriers in drug delivery. His laboratory, the Laboratory of Targeted Drug Delivery and Nanomedicine, serves as a hub for innovation in pharmaceutical nanotechnology.

Vadim CherezovView profile

Professor

• Membrane Protein Structure and Function
• G Protein-Coupled Receptors (GPCRs)
• Lipid-Protein Interactions
• +3 more

Vadim Cherezov, the Ester Dornsife Chair in Biological Sciences and Professor at the University of Southern California (USC), leads groundbreaking research in membrane protein structure and function. Affiliated with the Bridge Institute, Department of Chemistry, and Michelson Center for Convergent Bioscience, his work focuses on GPCRs, ion channels, and transporters—critical targets for drug discovery. His team leverages advanced techniques like Lipidic Cubic Phase (LCP) and Serial Femtosecond Crystallography (SFX) at XFEL facilities to solve high-resolution structures under physiological conditions. Institutional Affiliations: Bridge Institute, USC Michelson Center, Department of Chemistry, Department of Pharmacology and Pharmaceutical Sciences. Key Collaborations: Katritch Lab, Kuhn Lab, NIH, European XFEL. His research explores the role of lipids in modulating GPCR function, addressing diseases like Alzheimer’s, diabetes, and cancer. By solving the structure of the A 2A adenosine receptor via sulfur SAD phasing at XFEL, Cherezov’s lab demonstrated de novo phasing without heavy atoms. This breakthrough enables structural studies of previously intractable membrane proteins. Scientific Awards & Grants: NIH R01 GM108635, U54 GM094618, U54 GM094599, R01 GM095583 Science Signaling Breakthroughs of the Year (2014) Cherezov mentors a dynamic team, including postdocs (e.g., Dong-Gyun Kim), graduate students (e.g., Behnaz Davoudinasab), and alumni (e.g., Benjamin Stauch at Eli Lilly, Nairie Michaelian at Genentech). His lab’s publications span Nature , Science , and Cell , with recent work on Science Advances (2025) addressing ABEL-FRET for GPCR dynamics.

Claus LammView profile

Professor

• Empathy
• Prosocial Behavior
• Social Neuroscience
• +5 more

Claus Lamm is a Full Professor of Biological Psychology at the University of Vienna , where he leads the Social, Cognitive and Affective Neuroscience Unit (SCAN-Unit) . He serves as Vice Dean for Research and Advancement of Early Career Researchers at the Faculty of Psychology and holds affiliations with the Vienna Cognitive Science Hub , Environment & Climate Change Hub , and Austrian Academy of Sciences . His academic career spans international collaborations and formative research experience abroad. Scientific Focus: Lamm investigates the neural underpinnings of empathy and prosocial behavior , employing multi-modal approaches combining neuroimaging, psychopharmacology, and psychoneuroendocrinology . His work extends to comparative studies with ravens and dogs, and explores environmental social neuroscience through climate change decision-making research. Recent publications show trends in cross-cultural psychology , machine learning applications , and neurobiological pathways related to social behavior. Awards & Grants: Recipient of the APS Mentor Award for his support of early career researchers. Funded by European Research Council , Austrian Science Fund , Vienna Science and Technology Fund , and intramural grants exceeding €10 million. Key projects include "Unravelling the opioid system in empathy" and "Comparative dog-human fMRI" . Media Engagement: A prominent public science communicator, Lamm has appeared in Nature , Science Magazine , and Austrian media outlets like Ö1 Mittagsjournal and ORF2 , discussing topics from pandemic psychology to social media effects . He maintains active outreach through Science TV and educational programs .

• Security Engineering
• Science of Security
• Human-Computer Interaction
• +4 more

Janne Lindqvist is an Associate Professor at the Department of Computer Science, Aalto University. His research bridges security engineering, human-computer interaction (HCI), and privacy, with a focus on making security systems usable and user-centric. University: Aalto University Department: Department of Computer Science Rank: Associate Professor Email: janne.lindqvist@aalto.fi Lindqvist’s work spans security engineering , privacy systems , and user research , emphasizing practical authentication methods, password management, and human behavior in security contexts. He explores how users interact with systems like TPM APIs, gesture passwords, and mobile authentication mechanisms. Recent publications highlight trends in authentication systems , ubiquitous computing security , and mobile user behavior . Key themes include biometric authentication, gesture-based security, and balancing usability with cryptographic robustness. CHI'25 Honorable Mention Award CHI'24 Best Paper Award His research integrates empirical studies with technical implementations, such as analyzing password forgetting patterns and developing acoustic sensing for vehicle detection (e.g., Auto++, BO-Ear). Collaborative efforts span machine learning, psychology, and embedded systems.

Rotem KarniView profile

Associate Professor

• Alternative RNA Splicing
• RNA Biology
• Cancer Therapy
• +4 more

Rotem Karni, PhD, is an Associate Professor of Genetics at the Perelman School of Medicine, University of Pennsylvania, Philadelphia. He leads a research lab focused on understanding how alternative RNA splicing contributes to cancer and genetic diseases, with a strong emphasis on translating these findings into RNA-based therapies. Karni's lab develops decoy oligonucleotides, small molecules, and splice-switching technologies to modulate splicing factors and enhance immunotherapy. Education BSc in Biological Chemistry from The Hebrew University of Jerusalem (1997) PhD in Biological Chemistry from The Hebrew University of Jerusalem, Israel (2002) Postdoctoral Fellowship at Cold Spring Harbor Laboratory, NY (2002-2007) Karni's research explores the deregulation of alternative splicing in oncogenesis, particularly how splicing factors like RBFOX2 and S6K1 influence metastasis, DNA repair, and immune checkpoint modulation. His team investigates m6A RNA modifications for stabilizing mutant genes, with applications in Duchenne Muscular Dystrophy and pancreatic cancer. The lab's work is commercialized through biotech companies: SKIP Therapeutics, Andlit Therapeutics, and RNAble. Selected Research Trends RNA mis-splicing and neoantigen generation (2025) Splicing factor inhibition for tumor suppression (2023) Metastatic splicing signatures in pancreatic cancer (2023) Immune checkpoint splicing in cancer immunotherapy (2021) m6A modulation for mRNA stabilization (2023) Advising & Collaborations Karni has mentored numerous PhD and postdoctoral researchers, many of whom now hold leadership roles in academia, biotech, and medical institutions globally. His lab collaborates extensively on projects involving RNA innovation, including partnerships with the Institute for RNA Innovation. Contact Department of Genetics & Institute for RNA Innovation, One uCity Square, Room 4018, Philadelphia, PA 19104 Phone: 215-898-5072 Email: Rotem.Karni@Upenn.edu

Martin BurkeView profile

Professor

• Organic Chemistry
• Small-Molecule Synthesis
• Molecular Prosthetics
• +7 more

Martin Burke is the May and Ving Lee Professor for Chemical Innovation and Professor of Chemistry at the University of Illinois Urbana-Champaign , with additional appointments in Biochemistry, Biomedical & Translational Sciences, and multiple campus institutes including the Beckman Institute and the Carl R. Woese Institute for Genomic Biology. Education B.S. Johns Hopkins University , 1998 Ph.D. Harvard University , 2003 M.D. Harvard Medical School , 2003 Research Interests Burke’s program centers on molecular prosthetics : the design, synthesis and application of small molecules that replicate or replace missing or dysfunctional proteins. His group pioneered iterative cross-coupling (ICC) using MIDA-protected haloboronic acids to automate the construction of complex natural products and function-oriented small molecules. Current projects target ion-channel replacement in cystic fibrosis, iron-transport restoration in anemia, and non-toxic antifungals that overcome drug resistance. Scientific Awards & Honors National Academy of Medicine (2021) AAAS Fellow (2021) ASCI Member (2021) iCON Award (2019) Mukaiyama Award, Japan (2019) ACS Nobel Laureate Award for Graduate Education (2017) Thieme-IUPAC Prize in Synthetic Organic Chemistry (2014) Elias J. Corey Award (2013) Arthur C. Cope Scholar Award (2011) Research Output & Impact Burke has authored >120 peer-reviewed articles, >30 patents, and his work has been cited >20,000 times. High-impact publications in Nature , Science , and Angewandte Chemie have advanced automated synthesis, molecular prosthetics, and cystic fibrosis therapeutics. Laboratory & Training The Burke Laboratories house a multidisciplinary team of graduate students, post-doctoral researchers, and physician-scientists developing next-generation molecular prosthetics. The group is supported by NIH, NSF, private foundations, and industry partnerships aimed at democratizing molecular innovation.

Ron DrorView profile

Professor

• Computational Biology
• Machine Learning
• Molecular Dynamics Simulation
• +6 more

Ron Dror is the Cheriton Family Professor of Computer Science at the Stanford Artificial Intelligence Lab , with courtesy appointments in Structural Biology and Molecular & Cellular Physiology . He also holds affiliations with Bio-X, the Institute for Human-Centered Artificial Intelligence (HAI), the Institute for Computational and Mathematical Engineering (ICME), Sarafan ChEM-H, and the Wu Tsai Neurosciences Institute. Education: PhD in Electrical Engineering and Computer Science, MIT MPhil in Biological Sciences, University of Cambridge (Churchill Scholar) BS in Mathematics and Electrical & Computer Engineering, Rice University (summa cum laude) Ron leads a multidisciplinary research group that combines molecular simulation and machine learning to study biomolecular structure, dynamics, and function. His work focuses on developing computational methods to accelerate drug discovery by predicting molecular interactions and designing more effective therapeutics. Current projects include the PENSA software library for analyzing biomolecular ensembles and FRAME framework for structure-based ligand design. His research has produced groundbreaking work on G-protein-coupled receptors (GPCRs) , RNA structure prediction , and mitochondrial transport mechanisms . Key publications highlight applications of geometric deep learning and molecular dynamics simulations in structural biology. Scientific Awards: Cheriton Family Professorship (2023) Two Gordon Bell Prizes (2014, 2009) Best Paper Awards at NeurIPS (2021), IPDPS (2013), SC11 (2011), SC09 (2009), SC06 (2006) Science Magazine Top 10 Breakthrough (2010) Fulbright Scholarship , NSF Fellowship , DoD Fellowship , Whitaker Foundation Fellowship Ron has advised numerous doctoral and master’s students including EJ Fine , Masha Karelina , and Briana Sobecks . His lab collaborates with experimentalists across academia and industry, applying computational methods to diverse biomedical problems such as RNA structure prediction , GPCR signaling , and mitochondrial metabolism .

James T. EnnsView profile

Professor

• Perception
• Attention
• Vision
• +3 more

James T. Enns is a Professor and Distinguished University Scholar in the Department of Psychology within the Faculty of Arts at the University of British Columbia. His research primarily focuses on the role of attention in human vision, with secondary interests in developmental psychology and human-machine interaction. Dr. Enns' research interests span perception, attention, vision, cognition, development, and human-machine interaction. His work explores how the human mind selects information, with particular emphasis on visual attention mechanisms. His laboratory research investigates the fundamental processes of visual perception and how attention modulates these processes across different contexts and developmental stages. Analysis of Dr. Enns' publication record reveals consistent engagement with visual perception, attentional mechanisms, and cognitive processing. His research demonstrates expertise in both theoretical frameworks and experimental methodologies related to visual attention, with applications spanning basic cognitive science to potential implementations in human-computer interaction systems. His work often bridges theoretical cognitive psychology with practical applications. Canadian Society for Brain, Behaviour and Cognitive Science Donald O. Hebb Distinguished Contribution Award (2013) Distinguished University Scholar, UBC (2004) Robert E. Knox Master Teaching Award (2004) Royal Society of Canada Fellow (2002) Killam Faculty Research Prize (1994) Killam Faculty Research Fellowship (1993) Society of Experimental Psychology Fellow Dr. Enns has served as Editor for the Journal of Experimental Psychology: Human Perception and Performance, and as Associate Editor for Psychological Science, Consciousness and Cognition, and Visual Cognition. His research has been supported by grants from NSERC, the Canadian Foundation for Innovation, the Australian Research Council, BC Health, and Nissan. He has authored textbooks on perception, edited research volumes on the Development of Attention, and published numerous scientific articles on vision, attention, and cognitive science. Dr. Enns is currently accepting graduate students and continues to mentor the next generation of cognitive scientists. Dr. Enns leads the UBC Vision Lab, which focuses on how the human mind selects information. The lab conducts research on visual attention, perception, and cognitive processes using a variety of experimental methodologies.

• Neurosurgery
• Functional Neurosurgery
• Neuromodulation
• +3 more

Zion Zibly, MD, MBA is an Associate Professor in the Department of Neurosurgery at Yale School of Medicine . He holds multiple leadership roles including Director of the Center of Neuromodulation , Director of the Center of Neurosurgical Cancer Pain , and Head of Stereotactic & Functional Neurosurgery and the Focused Ultrasound Institute . Previously served as Chair of Neurosurgery at Sheba Medical Center after graduating from Technion’s Faculty of Medicine (MD) and Coller School of Management (MBA). Research Interests: Specializes in Neuromodulation for movement disorders (Parkinson’s, tremors, dystonia), Deep Brain Stimulation , Gene Therapy for pediatric neurodegenerative conditions, Oncological Neurosurgery , and Neurological Pain Management . Combines Functional Neurosurgery with Focused Ultrasound technology. Scientific Contributions: Participated in pioneering Alzheimer’s brain stimulator procedures and Gene Therapy applications. Active member of the North American Association of Functional Neurosurgery and Israeli Neurosurgical Society . Clinical Expertise: Implantation of electrostimulators for Parkinson’s and essential tremor, treatment of Benign/Malignant CNS Tumors , and management of Neurological Pain Conditions . Affiliated with Yale Cancer Center and Center for Brain & Mind Health .

Outi Salo-AhenView profile

Senior Lecturer

• Pharmaceutical Chemistry
• Molecular Modeling
• Drug Design
• +5 more

Senior Lecturer Outi Salo-Ahen is affiliated with Åbo Akademi University's Faculty of Natural Sciences and Engineering , Department of Pharmacy. Her research focuses on computational pharmacology, drug design, and pharmaceutical chemistry, particularly targeting chemokine receptors (CCR5/CXCR4) and transient receptor potential channels (TRPA1) for therapeutic applications. Doctor of Pharmacy (2006, University of Kuopio/UEF) MSc in Pharmaceutical Chemistry (2001, UEF) BSc in Pharmacy (1999, UEF) University Pedagogy Modules 1-5 (2012-2015) Her work contributes to UN Sustainable Development Goals through education and pharmaceutical innovation . Recent research trends include: Antimicrobial resistance solutions TRPA1 channel modulation Nanotechnology-enabled drug delivery Multi-target HIV-1 inhibitors 3D printing of biocompatible materials Computational analysis of nucleic acid frameworks She actively supervises doctoral projects, serves on assessment panels, and leads collaborations like Nordic Pharmaceutical Translation and Innovation. Her 60+ publications demonstrate expertise in molecular modeling and drug discovery.

• Developmental Psychophysiology
• Temperament and Personality Development
• Neuroscience of Shyness and Social Anxiety
• +4 more

Professor Louis Schmidt is a leading academic in the Department of Psychology, Neuroscience & Behaviour at McMaster University , with a research focus on developmental psychophysiology, temperament, and the long-term effects of early adversity. His work bridges neuroscience, psychology, and behavioral science, emphasizing the interplay between brain function and socio-emotional development across the lifespan. Key research themes: Shyness, social anxiety, autism spectrum disorder, schizophrenia, and outcomes of extremely low birth weight. Recognized for mentoring postdoctoral fellow Kristie Poole, who was celebrated as a role model in the Child Emotion Laboratory. Scientific Awards : Royal Society of Canada recognition for contributions to research and scholarship. Research Trends from 15 recent publications include: Neurophysiological mechanisms of shyness (EEG, ERP, RSA) Impact of antenatal corticosteroids on adult brain function Intergenerational effects of maternal mental health interventions Cross-cultural comparisons of temperamental shyness Developmental consequences of preterm birth Behavioral and neural correlates of social anxiety in diverse populations Grants & Collaborations : Led the SNACS randomized controlled trial on antenatal corticosteroids, with applications in obstetrics and developmental neuroscience. Collaborates extensively on topics like autism spectrum disorder, schizophrenia, and emotion regulation. Labs & Teams : Directs the Child Emotion Laboratory at McMaster University, fostering interdisciplinary research on developmental psychopathology and neural mechanisms of temperament.

• Sleep Biology
• Neurodevelopment
• Chronic Pain
• +5 more

Professor Richelle Mychasiuk, affiliated with the School of Medical Sciences at the University of Sydney, specializes in Sleep Biology and the neurobiological impacts of early life experiences. Her research focuses on how perinatal trauma and adverse childhood events shape neurodevelopment, increasing susceptibility to sleep disturbances, chronic pain, and post-concussive symptomologies in adolescents, with a particular emphasis on sex differences. Education: PhD in Neuroscience Her work explores mechanisms by which early life stressors "under the skin" to alter neuroplasticity and microbiome-gut-brain interactions. She co-founded The GIN hub, integrating Gastroenterology, Immunology, and Neuroscience to study complex chronic disease models. Recent articles highlight her contributions to understanding dietary influences on pain, epigenetic modifications, microbiome depletion effects, and neurovascular interventions in TBI models. Grants: 2025 FMH Start-up Scheme (Faculty of Medicine and Health, University of Sydney) Collaborations: Brain and Mind Centre, University of Sydney; clinical research partnerships for translational studies.

Chen RanView profile

Assistant Professor

• Interoceptive Processing
• Neurophysiology
• Brainstem Function
• +5 more

Chen Ran, PhD, is an Assistant Professor in the Department of Neuroscience at Scripps Research in San Diego. His laboratory focuses on understanding how the brain processes internal sensory signals from visceral organs, such as hunger, satiety, nausea, and visceral pain. Using advanced techniques like in vivo two-photon calcium imaging, optogenetics, and circuit tracing, his team maps the functional architecture of brainstem circuits responsible for interoceptive processing. Key contributions include the discovery of a 'visceral homunculus' in the brainstem and the development of novel calcium indicators for high-resolution neuronal activity tracking. Education : PhD in Biology, Stanford University (2017) Bachelor of Science in Biology, Peking University (2011) Research Interests : Dr. Ran’s work integrates experimental and analytical approaches to decode how visceral stimuli are transduced into conscious sensations. Current projects investigate the coding logic of mechanical, chemical, and thermal signals from internal organs, with implications for developing therapies for obesity, diabetes, visceral pain, and eating disorders. The lab employs cutting-edge tools to visualize and manipulate neural circuits in awake behaving mice, linking circuit-level activity to physiological states. Awards & Honors : NARSAD Young Investigator Award (2022) NIH K01 Career Development Award (2023) Simons Collaboration on the Global Brain Award (2022) Harvard Brain Science Initiative Award (2021) Grants & Funding : Supported by NIH, Simons Foundation, and private philanthropy, his research bridges basic science and translational medicine. Current grants focus on brainstem circuit mapping and developing therapeutic targets for interoceptive disorders. Labs & Affiliations : Dr. Ran leads an interdisciplinary team at Scripps Research’s Neuroscience Department, collaborating with engineers, geneticists, and clinicians to advance interoceptive neuroscience.

Kanwaljeet S. AnandView profile

Professor

• Pediatric Pain and Stress Neurobiology
• Neonatal and Fetal Pain Assessment
• Biomarker Development
• +3 more

Dr. Kanwaljeet S. Anand is a dual-appointed Professor of Pediatrics (Pediatric Critical Care) and Anesthesiology, Perioperative & Pain Medicine at Stanford University School of Medicine. As director of the Pain/Stress Neurobiology Lab and Jackson Vaughan Critical Care Research Fund, he serves as Editor-in-Chief of Pediatric Research and maintains active membership in Bio-X, MCHRI, and Wu Tsai Neurosciences Institute. Rhodes Scholar with D.Phil from University of Oxford Harvard postdoctoral fellowship and Boston Children's Hospital residency Founded Harmony Health Clinic - Arkansas' largest charitable medical-dental facility A translational researcher with 30+ years of impact, Dr. Anand established the first scientific framework for infant pain perception and developed novel pain assessment methodologies. Current research focuses on: Hair biomarker analysis for stress and social affiliation (cortisol/oxytocin) Machine learning systems for objective pain detection in non-verbal infants Biopsychosocial interventions for stress reduction in disadvantaged youth Neurotoxicity mechanisms of sedatives in developing brains Global NICU opioid usage patterns through the NeoOpioid Consortium His work has yielded over 260 publications and significant advances in: Pediatric pain management protocols Neonatal stress biomarker development Critical care neurobiology insights Community health initiatives AI-driven clinical decision support systems Scientific Recognition 9th Annual 'In Praise of Medicine' Public Address, Erasmus University (2014) Nightingale Excellence Award (2016) Honorary Doctorate from University of Örebro (2019) NIH SBIB-H82 Study Section Chair (2018) Multiple IASP and American Pain Society awards Swedish Academy of Medicine's Nils Rosén von Rosenstein Award (2009) St. Jude Endowed Chairholder (2010) As mentor to Med Scholar Anjali Gupta and advisor to numerous professional bodies, Dr. Anand maintains active clinical leadership in Pediatric Intensive Care while advancing computational approaches to pain detection through collaborations with Stanford's AI researchers.

Eva KosekView profile

Professor

• Chronic Pain Research
• Neuroimmunology
• Musculoskeletal Disorders
• +3 more

Professor Eva Kosek holds dual academic positions as Professor of Clinical Pain Research at Karolinska Institutet (since 2015) and Uppsala University (since 2020). She is affiliated with the Department of Clinical Neuroscience and leads the Mechanisms of Pain and Treatment Research Group . Her roles include senior consultant at Uppsala University Hospital's Pain Center. Education: MD from Uppsala University (1986), PhD from Karolinska Institutet (1996). Specializations: Rehabilitation Medicine (1998), Pain Relief (2001). Academic promotions: Associate Professor at Karolinska (2004), Full Professor (2015). Research Focus: Chronic pain mechanisms, neuroimmune interactions, fibromyalgia, and autoimmune pathways. Key projects include the RAFT trial (Rituximab for fibromyalgia autoantibody therapy) and the BACPAP consortium for low back pain phenotyping. She chairs IASP's Terminology Task Force, introducing the 'nociplastic pain' concept. Key Contributions: Discovered anti-satellite glial cell IgG antibodies in fibromyalgia patients, linked to symptom severity. Pioneered neuroimaging studies on pain modulation circuits. Authored over 300 publications, with recent work on cerebrospinal fluid biomarkers and lipid metabolite profiles. Awards: 2024 Roland Melzack Lecture Award from IASP. Recognized for redefining pain taxonomy and translational research. Grants: Active funding includes Swedish Research Council grants on fibromyalgia autoimmunity, environmental exposures, and neuroinflammation. Total grants exceed SEK 100M over her career. Labs/Teams: Leads a multidisciplinary team at Karolinska's Pain Research Center, collaborating internationally on translational pain studies. Active in biobanking initiatives like the Swedish Chronic Pain Biobank.